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Learn about the disease 
Get money for the project 
Get approval for the 
project 
Perform clinical research 
Perform biological 
research 
 
• How many corrected cells will I need to 
reach in a patient for a clinical benefit  
• Limits in gene transfer methodologies 
• good animal model to test both the efficacy 
& safety 
• A good antibody to track the re-expression 
of the missing protein 
Design a gene 
therapy. 
Get money and 
approval for clinical 
trials 
 
• A good correction of T lymphocyte 
function 
• Selective advantage of T modified 
lypmhocites. 
 
Perform clinical 
trial  
Get approval for 
general clinical 
use 
• An international phase I/II 
clinical trial for Wiskott-
Aldrich Syndrome (WAS) is 
performed in Genethon 
(France) 
 
 
 
 
A dialog between all parts involved in gene therapy is needed, with 
more information gene therapies would be more respected. That would 
increase investments and finally gene therapy would become an 
habitual clinical practise. 
I encourage everybody interested in gene therapies to visit the website 
(http://xavierrivera9.wix.com/gene-therapy1)  and  add comments to 
the forum. 
Nowadays it is indispensable to scale up the production of gene 
therapies because the diseases that we would be able to cure using a 
gene therapy would increase exponentially with new approaches. 
All the information of the steps involved in the application of a gene 
therapy to the Wiskott-Aldrich syndrome is more specifically detailed in 
the website. 
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Taking gene therapy from the laboratory to the clinic involves many 
factors that we usually neglect; in this review I will try to explain it 
using an example, the gene therapy for Wiskott-Aldrich syndrome. 
With more communication and information about gene therapy  it 
would be easier for society to accept that gene therapy is not 
something to fear, so I created a website with educational resources 
and a forum in order to make people understand what gene therapy 
really is.  
 
http://xavierrivera9.wix.com/gene-therapy1 
FORUM 
 
A real life example, gene therapy for Wiskott-Aldrich 
Syndrome 
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Introduction 
Objectives 
Xavier Rivera Martínez   Grau de Genètica, Facultat de Biociències, Universitat Autònoma de Barcelona 
• Link to the forum, a 
space to exchange 
opinions and points 
of view 
• Information about 
basic concepts of 
gene therapy and 
clinical trials 
• Videos to 
understand what 
gene therapy is. 
• Related experiences  
To study in which moment are gene therapies large scale 
production for blood disease with the example of the Wiskott-
Aldrich syndrome (WAS). 
To create a website for patients affected by rare diseases that 
could be susceptible of receiving gene therapy.  
To create a forum in order to promote opinion exchange 
between website users. No registration is needed.  
Website 
http://genetherapy.foromotion.es/ 
Conclusion 
Interviews 
To work in hematologic research 
you need a lot of enthusiasm, 
optimism, patience and to get 
down to work. But at the end of 
the hard work you will get your 
compensation in the form of 
results. (Dr Solé) 
We initially obtained a very good 
correction of T lymphocyte 
function by means of WAS gene 
transfer with retroviral vectors. 
(Dr Dupré) 
I believe the secret to translate the lab discoveries 
into clinical trials is to have a great team of 
specialists (MDs, scientists, regulatory affairs 
support, GMP trained support, research 
coordinators, nurses) and someone with a vision to 
coordinate all of them. (Dr Savoldo) 
 
Barbara Savoldo, a doctorate who works in the Texas Children Cancer Center 
Dr Francesc Solé, responsible of the research group in SMD of the Josep 
Carreras Research Institute against leukaemia 
Loïc Dupré, researcher in INSERM Toulouse who worked in Telethon Institute for 
Gene therapy in Milan. 
